---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-24-000028"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T12:00:48.135021+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# ICU Medical Q2 revenue up 8.6% to $596.5M but GAAP net loss widens to $21.4M; adjusted EPS down to $1.56

## Summary
- Revenue $596.5M up 8.6% YoY from $549.3M; GAAP gross margin 35% unchanged.
- GAAP net loss $(21.4)M ($0.88 loss per diluted share) vs $(9.9)M loss ($0.41) in Q2 2023.
- Adjusted diluted EPS $1.56 vs $1.88 YoY; adjusted EBITDA $91.3M down from $98.1M.
- Fiscal 2024 guidance updated; details not included in this excerpt.

## SEC filing metadata
- accession: 0000883984-24-000028
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/0000883984-24-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/icui-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-24-000028
- JSON: https://secwatch.observer/filing/0000883984-24-000028.json
- Plain text: https://secwatch.observer/filing/0000883984-24-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.